Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70
Identifieur interne : 001490 ( Main/Exploration ); précédent : 001489; suivant : 001491Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70
Auteurs : Silvia Mandel [Israël] ; Edna Grunblatt [Allemagne] ; Peter Riederer [Allemagne] ; Ninette Amariglio [Israël] ; Jasmine Jacob Hirsch [Israël] ; Gideon Rechavi [Israël] ; Moussa B. H. Youdim [Israël]Source :
- Annals of the New York Academy of SciencesNeuroprotective Agents: Seventh International Conference [ 0077-8923 ] ; 2005-08.
English descriptors
- KwdEn :
Abstract
Abstract: Sporadic Parkinson's disease (PD) constitutes 99% of the disorder, while the remaining 1% of the cases is of familial (genetic) origin. The mutations reported to be associated with familial PD indicate impairment in protein processing and misfolding, as is handled by the ubiquitin‐proteasome system (UPS), and in mitochondrial function. For these reasons, we have recently applied, for the first time, Affymetrix oligonucleotide microarray technique in the substantia nigra pars compacta of sporadic parkinsonian patients for studying global gene expression analysis and comparison to the alterations identified in inherited PD. This study identified decreased expression of 68 genes and elevation of 69 genes. Classification into functional groups revealed that the downregulated genes are related to signal transduction, protein degradation (e.g., ubiquitin‐proteasome subunits), dopaminergic transmission/metabolism, iron transport, protein modification/phosphorylation, and energy pathways/glycolysis functional classes. A major finding is the decreased expressions of 5 subunits of the UPS, SKP1A, a member of the SCF (E3) ubiquitin ligase complex, and chaperone HSC‐70, which can lead to a wide impairment in the function of an entire repertoire of proteins. The upregulated genes are clustered in cell adhesion/cytoskeleton, extracellular matrix components, cell cycle, protein modification/phosphorylation, protein metabolism and transcription, and inflammation/hypoxia (e.g., key iron and oxygen sensor EGLN1) classes. The study shows, for the first time, a convergence in the pathogenic processes that are observed in hereditary (familial) and sporadic PD, where abnormal iron metabolism, oxidative stress, and aggregation of proteins occur. An additional breakthrough in this research is the identification of a number of previously unsuspected crucial gene players that are also involved in the process of neurodegeneration, which can serve as specific biomarkers for PD and novel drug development.
Url:
DOI: 10.1111/j.1749-6632.2005.tb00044.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70</title><author><name sortKey="Mandel, Silvia" sort="Mandel, Silvia" uniqKey="Mandel S" first="Silvia" last="Mandel">Silvia Mandel</name></author><author><name sortKey="Grunblatt, Edna" sort="Grunblatt, Edna" uniqKey="Grunblatt E" first="Edna" last="Grunblatt">Edna Grunblatt</name></author><author><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name></author><author><name sortKey="Amariglio, Ninette" sort="Amariglio, Ninette" uniqKey="Amariglio N" first="Ninette" last="Amariglio">Ninette Amariglio</name></author><author><name sortKey="Hirsch, Jasmine Jacob" sort="Hirsch, Jasmine Jacob" uniqKey="Hirsch J" first="Jasmine Jacob" last="Hirsch">Jasmine Jacob Hirsch</name></author><author><name sortKey="Rechavi, Gideon" sort="Rechavi, Gideon" uniqKey="Rechavi G" first="Gideon" last="Rechavi">Gideon Rechavi</name></author><author><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B159AA7F22F759EF5B836174D5F96C04B9099DD1</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1749-6632.2005.tb00044.x</idno><idno type="url">https://api.istex.fr/document/B159AA7F22F759EF5B836174D5F96C04B9099DD1/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001090</idno><idno type="wicri:Area/Main/Curation">000E97</idno><idno type="wicri:Area/Main/Exploration">001490</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70</title><author><name sortKey="Mandel, Silvia" sort="Mandel, Silvia" uniqKey="Mandel S" first="Silvia" last="Mandel">Silvia Mandel</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence and Department of Pharmacology, Technion‐Rappaport Family Faculty of Medicine, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Grunblatt, Edna" sort="Grunblatt, Edna" uniqKey="Grunblatt E" first="Edna" last="Grunblatt">Edna Grunblatt</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute of Clinical Neurochemistry and National Parkinson Foundation Center of Excellence Laboratories, Clinic and Polyclinic for Psychiatry and Psychotherapy, Bayerische Julius‐Maximilians‐University of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute of Clinical Neurochemistry and National Parkinson Foundation Center of Excellence Laboratories, Clinic and Polyclinic for Psychiatry and Psychotherapy, Bayerische Julius‐Maximilians‐University of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author><author><name sortKey="Amariglio, Ninette" sort="Amariglio, Ninette" uniqKey="Amariglio N" first="Ninette" last="Amariglio">Ninette Amariglio</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Functional Genomics Unit, Institute of Hematology, Sheba Medical Center, Tel‐Aviv</wicri:regionArea><wicri:noRegion>Tel‐Aviv</wicri:noRegion></affiliation></author><author><name sortKey="Hirsch, Jasmine Jacob" sort="Hirsch, Jasmine Jacob" uniqKey="Hirsch J" first="Jasmine Jacob" last="Hirsch">Jasmine Jacob Hirsch</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Functional Genomics Unit, Institute of Hematology, Sheba Medical Center, Tel‐Aviv</wicri:regionArea><wicri:noRegion>Tel‐Aviv</wicri:noRegion></affiliation></author><author><name sortKey="Rechavi, Gideon" sort="Rechavi, Gideon" uniqKey="Rechavi G" first="Gideon" last="Rechavi">Gideon Rechavi</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Functional Genomics Unit, Institute of Hematology, Sheba Medical Center, Tel‐Aviv</wicri:regionArea><wicri:noRegion>Tel‐Aviv</wicri:noRegion></affiliation></author><author><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence and Department of Pharmacology, Technion‐Rappaport Family Faculty of Medicine, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of the New York Academy of SciencesNeuroprotective Agents: Seventh International Conference</title><idno type="ISSN">0077-8923</idno><idno type="eISSN">1749-6632</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2005-08">2005-08</date><biblScope unit="volume">1053</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="356">356</biblScope><biblScope unit="page" to="375">375</biblScope></imprint><idno type="ISSN">0077-8923</idno></series><idno type="istex">B159AA7F22F759EF5B836174D5F96C04B9099DD1</idno><idno type="DOI">10.1111/j.1749-6632.2005.tb00044.x</idno><idno type="ArticleID">NYAS356</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0077-8923</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Affymetrix</term><term>HSC‐70</term><term>MPTP</term><term>Parkinson's disease (PD)</term><term>SKP1A</term><term>apoptosis</term><term>cerebellum</term><term>gene expression</term><term>hypoxia</term><term>inflammatory process</term><term>iron</term><term>microarray</term><term>oxidative stress</term><term>quantitative real‐time PCR</term><term>substantia nigra pars compacta</term><term>ubiquitin‐proteasome system</term><term>α‐synuclein</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Sporadic Parkinson's disease (PD) constitutes 99% of the disorder, while the remaining 1% of the cases is of familial (genetic) origin. The mutations reported to be associated with familial PD indicate impairment in protein processing and misfolding, as is handled by the ubiquitin‐proteasome system (UPS), and in mitochondrial function. For these reasons, we have recently applied, for the first time, Affymetrix oligonucleotide microarray technique in the substantia nigra pars compacta of sporadic parkinsonian patients for studying global gene expression analysis and comparison to the alterations identified in inherited PD. This study identified decreased expression of 68 genes and elevation of 69 genes. Classification into functional groups revealed that the downregulated genes are related to signal transduction, protein degradation (e.g., ubiquitin‐proteasome subunits), dopaminergic transmission/metabolism, iron transport, protein modification/phosphorylation, and energy pathways/glycolysis functional classes. A major finding is the decreased expressions of 5 subunits of the UPS, SKP1A, a member of the SCF (E3) ubiquitin ligase complex, and chaperone HSC‐70, which can lead to a wide impairment in the function of an entire repertoire of proteins. The upregulated genes are clustered in cell adhesion/cytoskeleton, extracellular matrix components, cell cycle, protein modification/phosphorylation, protein metabolism and transcription, and inflammation/hypoxia (e.g., key iron and oxygen sensor EGLN1) classes. The study shows, for the first time, a convergence in the pathogenic processes that are observed in hereditary (familial) and sporadic PD, where abnormal iron metabolism, oxidative stress, and aggregation of proteins occur. An additional breakthrough in this research is the identification of a number of previously unsuspected crucial gene players that are also involved in the process of neurodegeneration, which can serve as specific biomarkers for PD and novel drug development.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Israël</li></country><region><li>Bavière</li><li>District de Basse-Franconie</li></region><settlement><li>Wurtzbourg</li></settlement></list><tree><country name="Israël"><noRegion><name sortKey="Mandel, Silvia" sort="Mandel, Silvia" uniqKey="Mandel S" first="Silvia" last="Mandel">Silvia Mandel</name></noRegion><name sortKey="Amariglio, Ninette" sort="Amariglio, Ninette" uniqKey="Amariglio N" first="Ninette" last="Amariglio">Ninette Amariglio</name><name sortKey="Hirsch, Jasmine Jacob" sort="Hirsch, Jasmine Jacob" uniqKey="Hirsch J" first="Jasmine Jacob" last="Hirsch">Jasmine Jacob Hirsch</name><name sortKey="Rechavi, Gideon" sort="Rechavi, Gideon" uniqKey="Rechavi G" first="Gideon" last="Rechavi">Gideon Rechavi</name><name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name></country><country name="Allemagne"><region name="Bavière"><name sortKey="Grunblatt, Edna" sort="Grunblatt, Edna" uniqKey="Grunblatt E" first="Edna" last="Grunblatt">Edna Grunblatt</name></region><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001490 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001490 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B159AA7F22F759EF5B836174D5F96C04B9099DD1
|texte= Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70
}}
| This area was generated with Dilib version V0.6.23. |  |